• Figure 1.

    Strategies for the prevention of bloodstream infections in patients receiving hemodialysis

  • Figure 2.

    Access-related bloodstream infection rates before and after intervention in 17 hemodialysis facilities participating in the CDC Dialysis Bloodstream Infection Prevention Collaborative

  • Figure 3.

    Example of the Electronic Chairside Checklist 2020, which is in development by the Nephrologists Transforming Dialysis Safety (NTDS) Vascular Access Workgroup of the American Society of Nephrology and the Centers for Disease Control and Prevention

  • Figure 4.

    Example of the patient education tools embedded in the Electronic Chairside Checklist. These include videos produced by the Centers for Disease Control and Prevention (CDC). In development by the Nephrologists Transforming Dialysis Safety (NTDS) Vascular Access Workgroup of the American Society of Nephrology with the CDC.

  • 1.

    U.S. Renal Data System. 2019 USRDS annual data report: Section 2: End-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2018.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Nguyen DB, et al. National healthcare safety network (NHSN) dialysis event surveillance report for 2014. Clin J Am Soc Nephrol 2017; 12:11391146.

  • 3.

    Fisher M, et al. Prevention of bloodstream infections in patients undergoing hemodialysis. Clin J Am Soc Nephrol 202; 15:132151.

  • 4.

    Centers for Disease Control and Prevention. Dialysis safety core interventions, 2016. https://www.cdc.gov/dialysis/prevention-tools/core-interventions.html.

  • 5.

    Mimoz O, et al. Skin antisepsis with chlorhexidine–alcohol versus povidone iodine–alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): An open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet 2015; 386:20692077.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Rosenblum A, et al. Hemodialysis catheter care strategies: A cluster-randomized quality improvement initiative. Am J Kidney Dis 2014; 63:259267.

  • 7.

    Apata IW, et al. Chlorhexidine-impregnated transparent dressings decrease catheter-related infections in hemodialysis patients: A quality improvement project. J Vasc Access 2017; 18:103108.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Hymes JL, et al. Dialysis catheter-related bloodstream infections: A cluster-randomized trial of the ClearGuard HD antimicrobial barrier cap. Am J Kidney Dis 2016; 69:220227.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Brunelli SM, et al. Cluster-randomized trial of devices to prevent catheter-related bloodstream infection. J Am Soc Nephrol 2018; 29:13361343.

  • 10.

    Landry DL, et al. Emergence of gentamycin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol 2010; 5:17991804.

  • 11.

    Moran J, et al. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients. Am J Kidney Dis 2012; 59:102107.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12.

    Moore CL, et al. Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients. Clin J Am Soc Nephrol 2014; 9:12321239.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13.

    Hemmelgarn BR, et al. Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med 2011; 364:303312.

  • 14.

    Agarwal A, et al. Lock-It-100: Crmd003, a novel taurolidine-based catheter lock solution reduces catheter-related bloodstream infections in hemodialysis [Abstract]. Am J Kidney Dis 2019; 73:898902.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15.

    Broom JK, et al. A randomized controlled trial of heparin versus ethanol lock therapy for the prevention of catheter associated infection in haemodialysis patients—the HEALTHY-CATH trial. BMC Nephrol 2012; 13:146.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16.

    Sofroniadou S, et al. Ethanol combined with heparin as a locking solution for the prevention of catheter related blood stream infections in hemodialysis patients: A prospective randomized study. Hemodial Int 2017; 21:498506.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17.

    El-Hennawy AS, et al. Sodium bicarbonate catheter lock solution reduces hemodialysis catheter loss due to catheter-related thrombosis and blood stream infection: An open-label clinical trial. Nephrol Dial Transplant 2019; 34:17391745.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18.

    Patel PR, et al. Bloodstream infection rates in outpatient hemodialysis facilities participating in a collaborative prevention effort: A quality improvement report. Am J Kidney Dis 2013; 62:322330.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation

Preventing Bloodstream Infections in Hemodialysis Patients

Michele H. Mokrzycki Michele H. Mokrzycki, MD, FASN, is chair of the vascular access committee, Nephrologists Transforming Dialysis Safety Initiative of the American Society of Nephrology, and a professor of medicine at the Montefiore Einstein College of Medicine.

Search for other papers by Michele H. Mokrzycki in
Current site
Google Scholar
PubMed
Close
Restricted access
Save